Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2021.5244
Abstract: Importance Clopidogrel monotherapy after short dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has not yet been fully investigated in patients with acute coronary syndrome (ACS). Objective To test the hypothesis of noninferiority of… read more here.
Keywords: dual antiplatelet; clopidogrel monotherapy; months dapt; antiplatelet therapy ... See more keywords
Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.4000
Abstract: Key Points Question What is the optimal duration of dual antiplatelet therapy (DAPT) in terms of net adverse clinical events, major cardiovascular events, and bleeding for older adults after percutaneous coronary intervention (PCI)? Findings In… read more here.
Keywords: months dapt; risk; adults percutaneous; dual antiplatelet ... See more keywords
Validation of the DAPT score in real-world patients undergoing coronary stent implantation.
Sign Up to like & getrecommendations! Published in 2019 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2019.08.044
Abstract: OBJECTIVES To assess the external validity of the Dual Antiplatelet Therapy (DAPT) score decision tool in real world patients. METHODS AND RESULTS Retrospective study using an all comers PCI registry. We compared the rates of… read more here.
Keywords: world patients; real world; dapt score; score ... See more keywords